BioTime, Inc. (NYSEMKT:BTX)

CAPS Rating: 3 out of 5

BTX News and Commentary

Caps

How do you think BTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

64 Outperform
36 Underperform
 

All-Star Players

3 Outperform
12 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top BTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

adi101 (82.38)
Submitted April 12, 2015

What an awesome company. Stem Cell medicine is the medicine of the future. BTX is the 700 pounds IP gorilla. Multiple Clinical tests, Fantastically Financially astute leadership, (relatively little dilution), Wide open markets, multiples plans to… More

ShortSeller58 (81.15)
Submitted May 24, 2014

Never earned a penny. No different than the 100 other micro pharmaceutical. companies hoping to find the "next big thing." Short this stock until the cows come home!

BTX VS S&P 500 (SPY)

Fools bullish on BTX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about BTX.

Recs

0
Member Avatar DarthMaul09 (29.16) Submitted: 10/9/2017 3:28:46 AM : Outperform Start Price: $2.85 BTX Score: -9.51

Some interesting news coming out biotech stocks. In the past the hype seems greater than the facts but after some recent success with treatment for Hepatitis C and some difficult to treat cancers, it appears that there may be some hope for real profits prior to all the cash being burned. With the stock price falling over the last two years and real hope now for some success, there may be a buying opportunity opening up. I'm gradually adding into a position 20% at a time then waiting.
If it continues to go down I'll have a full position by the end of the year. A lot of older people with money might want to spend some of their cash to avoid the aches an pains of old age.

Recs

1
Member Avatar adi101 (82.38) Submitted: 4/12/2015 6:04:23 AM : Outperform Start Price: $4.48 BTX Score: -181.31

What an awesome company. Stem Cell medicine is the medicine of the future. BTX is the 700 pounds IP gorilla. Multiple Clinical tests, Fantastically Financially astute leadership, (relatively little dilution), Wide open markets, multiples plans to unlock value, short term revenues bearing initiatives, what’s not to like?. My bet here is that this is the INTEL of Stem Cell Medicine. When the first few indication get FDA clearance, and the world realizes Stem Cell Medicine is not Sci-Fi but a here and now, watch is fire away. So many things going on, holding it is like investing in 6-12 companies. Don’t miss out.

Recs

1
Member Avatar ShortSeller58 (81.15) Submitted: 5/24/2014 2:36:42 PM : Underperform Start Price: $2.35 BTX Score: +22.23

Never earned a penny. No different than the 100 other micro pharmaceutical. companies hoping to find the "next big thing." Short this stock until the cows come home!

Leaderboard

Find the members with the highest scoring picks in BTX.

Score Leader

Beorn10

Beorn10 (29.36) Score: +215.64

The Score Leader is the player with the highest score across all their picks in BTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Infantryman11 < 20 10/5/2009 11/6/2009 Underperform 1Y $5.40 -51.48% +148.27% +199.75 0 Comment
ReadEmAnWeep 67.67 10/1/2009 Underperform 5Y $5.72 -54.20% +142.52% +196.72 0 Comment
MstrGold 29.44 5/21/2010 Underperform 5Y $5.54 -52.71% +141.21% +193.92 0 Comment
iK89 48.92 9/30/2009 Underperform 3M $5.60 -53.21% +140.19% +193.41 0 Comment
StanTheMan22 94.08 10/23/2009 Underperform 5Y $5.95 -55.97% +136.44% +192.40 0 Comment
foolergo8888 29.73 9/23/2009 Underperform 5Y $5.60 -53.21% +138.05% +191.26 0 Comment
mathieugp 24.41 9/28/2009 Underperform 3M $4.60 -43.04% +143.65% +186.70 0 Comment
roth450 28.19 7/27/2010 Underperform NS $6.34 -58.68% +127.75% +186.43 0 Comment
Displacement < 20 9/29/2009 Underperform 1Y $4.27 -38.57% +139.86% +178.43 1 Comment
Korodas 76.96 9/1/2010 Underperform NS $4.32 -39.35% +135.87% +175.22 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackwbbsecuriti < 20 8/11/2011 Outperform NS $4.47 -41.39% +125.56% -166.95 0 Comment
TrackBioLogicEqu < 20 1/6/2011 Underperform NS $8.60 -69.53% +100.07% +169.61 0 Comment

Featured Broker Partners